0001209191-16-142490.txt : 20160922 0001209191-16-142490.hdr.sgml : 20160922 20160922165305 ACCESSION NUMBER: 0001209191-16-142490 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160921 FILED AS OF DATE: 20160922 DATE AS OF CHANGE: 20160922 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: aTYR PHARMA INC CENTRAL INDEX KEY: 0001339970 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203435077 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 3545 JOHN HOPKINS COURT, STE #250 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-731-8389 MAIL ADDRESS: STREET 1: 3545 JOHN HOPKINS COURT, STE #250 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: King David John CENTRAL INDEX KEY: 0001684902 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37378 FILM NUMBER: 161898049 MAIL ADDRESS: STREET 1: 3545 JOHN HOPKINS COURT STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-09-21 0 0001339970 aTYR PHARMA INC LIFE 0001684902 King David John 3545 JOHN HOPKINS COURT SUITE 250 SAN DIEGO CA 92121 0 1 0 0 See Remarks Employee Stock Option (right to buy) 3.29 2016-09-21 4 A 0 145000 0.00 A 2026-09-21 Common Stock 145000 145000 D 1/4 of the shares subject to this option shall vest and become exercisable on September 21, 2017, and the remainder shall thereafter vest in 36 equal monthly installments, such that this option is fully exercisable on September 21, 2020. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. Senior Vice President, Research Nancy D. Krueger, attorney-in-fact 2016-09-22